Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMOX + Sorafenib in Advanced Biliary Tract Cancer
NCT00955721Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Aug 2009
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in biliary tract cancer (BTC), cholangiocarcinoma (CCA), gallbladder cancer, sponsored by University of Miami. Started Aug 2009; status: terminated.
02
Drugs
sorafenib
03
Conditions
biliary tract cancer (BTC)cholangiocarcinoma (CCA)gallbladder cancer
Beyond the preview
Go deeper on NCT00955721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00955721.